Full Press Release Details
ACG
has strengthened its global executive leadership team with the appointment of
Lalit Kasliwal as Group Chief Financial Officer, reinforcing the company’s
commitment to accelerating international growth and strengthening financial
strategy and governance across its pharmaceutical and nutraceutical
manufacturing businesses.
As
Group Chief Financial Officer, Lalit Kasliwal will lead ACG’s global finance
function, driving financial strategy, treasury, governance, capital allocation
and risk management to support the Group’s long-term ambitions.
Lalit
Kasliwal brings more than 27 years of global leadership experience in financial
strategy, treasury, capital allocation and structuring, governance, enterprise
transformation and risk management across the pharmaceutical, manufacturing and
international trading sectors.
He
joins ACG from Tata International Limited, where he served as Chief Financial
Officer and Company Secretary, leading the global finance function for
operations across more than 29 countries. Prior to this, he served as CFO –
Group Manufacturing and Head of Group Insurance at Reliance Industries Limited.
Earlier in his career, he held senior finance leadership positions with Vedanta
Group (Hindustan Zinc Limited and Sterlite Technologies Limited), Ruia Group
and IPCA Laboratories Limited.
Karan
Singh, Managing Director at ACG, commented: “We are delighted to welcome Lalit
to ACG. He brings a wealth of global experience, a strong track record of
financial leadership and a deep understanding of complex international
businesses. His expertise will be invaluable as we continue to strengthen our
operations and pursue the next phase of our growth strategy.”
Lalit
Kasliwal added: “I am delighted to be joining ACG at an exciting stage of its
global growth journey. I look forward to partnering with colleagues across the
organisation to strengthen financial performance, enhance governance and
support sustainable long-term value creation for our customers, partners and
stakeholders.”
The
appointment comes as ACG continues to expand its global presence and invest in
technologies and solutions that support pharmaceutical and nutraceutical
manufacturers worldwide.
About ACG
For sixty five years, ACG has been
innovating production solutions for pharmaceutical and nutraceutical companies.
As the world’s most integrated provider
of oral dosage products and services, ACG produces capsules, barrier packaging
materials, manufacturing machinery, and inspection and traceability solutions,
all compliant with international standards.
ACG partners with customers in 138
countries to solve complex manufacturing challenges and improve global health
outcomes.